Company attributes
B2X
Number of Employees (Ranges)
1 – 100
Full Address
New York, NY 11217, US
235 Montgomery Street, Suite 1230 San Francisco, California, 94104
Founded Date
2018
0Venture Capital Firm attributes
Invested in
...
Other attributes
Company Operating Status
Active
Adjuvant Capital is a venture capital firm that prefers to invest in businesses in the life science sector. Founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz in New York, New York. The firm invests in Early Stage Venture. The notable investment portfolio of the Adjuvant Capital includes AN2 Therapeutics, Themis, InDevR, and X-Vax.
As of December 2019, Sony Innovation Fund has made 4 investments and actively looking for new investment opportunities. Adjuvant Capital typically invests around $10-$25 million.
Timeline
No Timeline data yet.
